Loading dose of vancomycin in critically ill patients: 15 mg/kg is a better choice than 500 mg

被引:33
作者
Mohammedi, I [1 ]
Descloux, E [1 ]
Argaud, L [1 ]
Le Scanff, J [1 ]
Robert, D [1 ]
机构
[1] Edouard Herriot Univ Hosp, Med ICU, F-69003 Lyon, France
关键词
loading dose; vancomycin; ICU;
D O I
10.1016/j.ijantimicag.2005.11.009
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
Delays in antimicrobial therapy in high-risk patients with infection may have deleterious effects on clinical outcomes. Therefore, appropriate treatment must be initiated promptly. The objective of this prospective study was to determine the better loading dose of vancomycin in critically ill patients with suspected Gram-positive infections. Two groups of patients were studied successively: Group A, loading dose of 500 mg; and Group B, loading dose of 15 mg/kg. The mean post-loading dose serum vancornycin concentration was significantly higher in Group B than in GroupA (19.1 +/- 7.4 mg/L versus 10.4 +/- 2.7 mg/L; P < 0.001), without producing toxic peak levels. Clinical cure rates were significantly different for infected patients in Group B compared with Group A: 93% (14 of 15 patients) versus 56% (10 of 18 patients), respectively. However, the proportion of patients surviving to Intensive Care Unit discharge was similar. Because vancomycin is believed to achieve maximum killing at concentrations in serum of four to five times the minimum inhibitory concentration for the infecting organism, our results suggest that the 15 mg/kg loading dose should be preferred. (c) 2006 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:259 / 262
页数:4
相关论文
共 19 条
[1]
ANALYSIS OF VANCOMYCIN TIME-KILL STUDIES WITH STAPHYLOCOCCUS SPECIES BY USING A CURVE STRIPPING PROGRAM TO DESCRIBE THE RELATIONSHIP BETWEEN CONCENTRATION AND PHARMACODYNAMIC RESPONSE [J].
ACKERMAN, BH ;
VANNIER, AM ;
EUDY, EB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1766-1769
[2]
Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit [J].
Albanèse, J ;
Léone, M ;
Bruguerolle, B ;
Ayem, ML ;
Lacarelle, B ;
Martin, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) :1356-1358
[3]
DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[4]
Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion [J].
Byl, B ;
Jacobs, F ;
Wallemacq, P ;
Rossi, C ;
de Francquen, P ;
Cappello, M ;
Leal, T ;
Thys, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (06) :2015-2017
[5]
CONTINUOUS INFUSION OF BETA-LACTAM ANTIBIOTICS [J].
CRAIG, WA ;
EBERT, SC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) :2577-2583
[6]
Loading dose of vancomycin: is there a consensus view? [J].
Descloux, E ;
Mohammedi, I .
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2004, 23 (07) :755-755
[7]
HOW VANCOMYCIN IS USED IN AUSTRALASIA - A SURVEY [J].
DUFFULL, SB ;
CHAMBERS, ST ;
BEGG, EJ .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1993, 23 (06) :662-666
[8]
FELMINGHAM D, 1999, CLIN ANTIMICROBIAL A
[9]
SURVEY OF VANCOMYCIN MONITORING GUIDELINES IN ILLINOIS HOSPITALS [J].
FITZSIMMONS, WE ;
POSTELNICK, MJ ;
TORTORICE, PV .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (7-8) :598-600
[10]
CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140